Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
This change was narrower than the S&P 500's daily loss of 1.23%. Meanwhile, the Dow lost 1.36%, and the Nasdaq, a tech-heavy index, lost 1.4%. Heading into today, shares of the specialty pharmaceutical company had lost 9.44% over the past month, lagging the Medical sector's loss of 1.23% and the S&P 500's gain of 1.61% in that time. The upcoming earnings release of Amphastar Pharmaceuticals will be of great interest to investors. It is anticipated that the company will report an EPS of $0.73, marking a 17.74% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $169 million, indicating a 20.7% growth compared to the corresponding quarter of the prior year. AMPH's full-year Zacks Consensus Estimates are calling for earnings of $3.71 per share and revenue of $764.43 million. These results would represent year-over-year changes of +11.75% and +18.63%, respectively. Any recent changes to analyst estimat
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth [Yahoo! Finance]Yahoo! Finance
- Pharvaris appoints David Nassif as chief financial officer [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
- Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare ConferenceAccesswire
- Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 2/28/24 - Beat
AMPH
Sec Filings
- 4/19/24 - Form DEFA14A
- 4/12/24 - Form ARS
- 4/12/24 - Form DEFA14A
- AMPH's page on the SEC website